Loading insider details...
Beta
Latest Form 4 (Sep 15, 2026): Grant/Award of 14,343 NBIX shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 15, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 14,343 | n/a |
| Jul 8, 2026 | Xencor Inc (XNCR) | Grant/Award | 10,302 | n/a |
| Jun 17, 2026 | Xencor Inc (XNCR) | Sale | 7,527 | $92.7K |
| May 29, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Grant/Award | 5,248 | n/a |
| May 21, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 205,088 | $8.87M |
| Feb 17, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 5,604 | n/a |
| Feb 3, 2026 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 5,142 | n/a |
| Aug 11, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Exercise/Conversion | 106,322 | $3.83M |
| Jun 16, 2025 | Xencor Inc (XNCR) | Grant/Award | 13,686 | n/a |
| May 29, 2025 | NEUROCRINE BIOSCIENCES INC (NBIX) | Sale | 9,613 | $1.16M |